Travel & Learn
-
Franchise India Bureau Aug 02 2018 - 1 min readChina based Nasdaq-listed biotech firm BeiGene Ltd has raised $903 million after pricing its secondary listing in Hong Kong the first under new exchange rules near the top of an indicative range, three people close to the deal said on Thursday. The listing was revealed Hong Kong has been into the gaining the international firms ...